Published in Cancer Res on February 01, 2000
The role of fibroblast growth factors in tumor growth. Curr Cancer Drug Targets (2009) 1.52
Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist. PLoS One (2010) 1.23
Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels. Am J Pathol (2007) 1.12
The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion. Cell Cycle (2013) 1.08
Molecular pathology of the fibroblast growth factor family. Hum Mutat (2009) 1.06
Grb2 controls phosphorylation of FGFR2 by inhibiting receptor kinase and Shp2 phosphatase activity. J Cell Biol (2013) 0.92
The interplay between hypoxia, endothelial and melanoma cells regulates vascularization and cell motility through endothelin-1 and vascular endothelial growth factor. Carcinogenesis (2014) 0.88
High molecular weight FGF2: the biology of a nuclear growth factor. Cell Mol Life Sci (2009) 0.84
Ligand-dependent corepressor contributes to transcriptional repression by C2H2 zinc-finger transcription factor ZBRK1 through association with KRAB-associated protein-1. Nucleic Acids Res (2014) 0.83
Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity. J Cell Biochem (2014) 0.82
An Approach to Breast Cancer Diagnosis via PET Imaging of Microcalcifications Using (18)F-NaF. J Nucl Med (2014) 0.82
Dual FGF-2 and intergrin alpha5beta1 signaling mediate GRAF-induced RhoA inactivation in a model of breast cancer dormancy. Cancer Microenviron (2009) 0.79
A design principle underlying the paradoxical roles of E3 ubiquitin ligases. Sci Rep (2014) 0.79
FGF signaling inhibits the proliferation of human myeloma cells and reduces c-myc expression. BMC Cell Biol (2003) 0.78
Axl activates fibroblast growth factor receptor pathway to potentiate survival signals in B-cell chronic lymphocytic leukemia cells. Leukemia (2015) 0.75
GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment. Nat Commun (2016) 0.75
1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Res (2000) 1.26
1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects. Breast Cancer Res Treat (2001) 1.04
Relation of thymidine index to pulmonary tumor response in mice receiving urethan and other carcinogens. Cancer Res (1969) 0.95
Carcinogens from fungi pathogenic for man. Cancer Res (1968) 0.92
Overexpression of basic fibroblast growth factor (FGF-2) downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells. Breast Cancer Res Treat (1999) 0.85
Intracellular FGF-2 promotes differentiation in T-47D breast cancer cells. Biochem Biophys Res Commun (2000) 0.85
Gene transfer into primates and prospects for gene therapy in humans. Prog Nucleic Acid Res Mol Biol (1989) 0.84
Levels of 3-methylcholanthrene and 7, 12-dimethylbenz[alpha]anthracene in rat mammary fat pads after intragastric administration, and relationships to carcinogenic response. J Natl Cancer Inst (1967) 0.84
Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events. Cancer Res (1997) 0.84
Photoinduced affinity labeling of the Escherichia coli ribosome puromycin site. Biochemistry (1978) 0.82
Factors affecting the kinetics of DNA reassociation in phenol-water emulsion at high DNA concentrations. Biopolymers (1982) 0.80
Role of transforming growth factor beta in the growth inhibition of human breast cancer cells by basic fibroblast growth factor. Breast Cancer Res Treat (2001) 0.79
Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells. Exp Cell Res (1998) 0.79
Pulmonary tumors in strain A mice given injections of aflatoxin B1. J Natl Cancer Inst (1968) 0.78
Lung tumor response in strain A mice as a quantitative bioassay of carcinogenic activity of some carbamates and aziridines. Cancer Res (1969) 0.77
Investigation of fatty acids and derivatives for carcinogenic activity. Cancer Res (1970) 0.76
Basic fibroblast growth factor confers growth inhibition and mitogen-activated protein kinase activation in human breast cancer cells. Clin Cancer Res (1997) 0.76
Replication of low-level carcinogenic activity bioassays. Cancer Res (1972) 0.75
Basic fibroblast growth factor potentiates cisplatinum-induced cytotoxicity in MCF-7 human breast cancer cells. J Cancer Res Clin Oncol (1999) 0.75